About Daniel Wildman
Daniel Wildman is a director at PanTher Therapeutics.
Daniel Wildman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Wildman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Wildman works with at each company, as listed on that company's latest Form D.
PanTher Therapeutics, Inc. · Form D, Apr 3, 2025
LI
Laura Indolfi
Chief Executive Officer and director
DM
D Mackey
Director
DZ
Darshana Zaveri
Director
MP
Maria Palasis
Director